[1]
Pantazi E, Zaouali MA, Bejaoui M, Folch-Puy E, Ben Abdennebi H, Roselló-Catafau J. Role of sirtuins in ischemia-reperfusion injury. World J Gastroenterol 2013; 19(43): 7594-602.
[http://dx.doi.org/10.3748/wjg.v19.i43.7594] [PMID: 24616566]
[http://dx.doi.org/10.3748/wjg.v19.i43.7594] [PMID: 24616566]
[2]
Soares ROS, Losada DM, Jordani MC, Évora P. Castro-E-Silva O. Ischemia/reperfusion injury revisited: An overview of the latest pharmacological strategies. Int J Mol Sci 2019; 20(20): E5034.
[http://dx.doi.org/10.3390/ijms20205034] [PMID: 31614478]
[http://dx.doi.org/10.3390/ijms20205034] [PMID: 31614478]
[3]
Nakazato PCG, Victorino JP, Fina CF, et al. Liver ischemia and reperfusion injury. Pathophysiology and new horizons in preconditioning and therapy. Acta Cir Bras 2018; 33(8): 723-35.
[http://dx.doi.org/10.1590/s0102-865020180080000008] [PMID: 30208134]
[http://dx.doi.org/10.1590/s0102-865020180080000008] [PMID: 30208134]
[4]
Cannistrà M, Ruggiero M, Zullo A, et al. Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers. Int J Surg 2016; 33(Suppl. 1): S57-70.
[http://dx.doi.org/10.1016/j.ijsu.2016.05.050] [PMID: 27255130]
[http://dx.doi.org/10.1016/j.ijsu.2016.05.050] [PMID: 27255130]
[5]
Briston T, Roberts M, Lewis S, et al. Mitochondrial permeability transition pore: Sensitivity to opening and mechanistic dependence on substrate availability. Sci Rep-Uk 2017; p. 7.
[6]
Görlach A, Bertram K, Hudecova S, Krizanova O. Calcium and ROS: A mutual interplay. Redox Biol 2015; 6: 260-71.
[http://dx.doi.org/10.1016/j.redox.2015.08.010] [PMID: 26296072]
[http://dx.doi.org/10.1016/j.redox.2015.08.010] [PMID: 26296072]
[7]
Matsumoto T, O’Malley K, Efron PA, et al. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 2006; 140(5): 793-802.
[http://dx.doi.org/10.1016/j.surg.2006.04.010] [PMID: 17084723]
[http://dx.doi.org/10.1016/j.surg.2006.04.010] [PMID: 17084723]
[8]
Oliveira CPMS, Lopasso FP, Laurindo FRM, Leitão RMC, Laudanna AA. Protection against liver ischemia-reperfusion injury in rats by silymarin or verapamil. Transplant Proc 2001; 33(6): 3010-4.
[http://dx.doi.org/10.1016/S0041-1345(01)02288-6] [PMID: 11543828]
[http://dx.doi.org/10.1016/S0041-1345(01)02288-6] [PMID: 11543828]
[9]
Li J, Li RJ, Lv GY, Liu HQ. The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury. Eur Rev Med Pharmaco 2015; 19(11): 2036-47.
[PMID: 26125267]
[PMID: 26125267]
[10]
Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Molecular pathways in protecting the liver from ischaemia/reperfusion injury: A 2015 update. Clin Sci (Lond) 2015; 129(4): 345-62.
[http://dx.doi.org/10.1042/CS20150223] [PMID: 26014222]
[http://dx.doi.org/10.1042/CS20150223] [PMID: 26014222]
[11]
Little PJ, Askew CD, Xu S, Kamato D. Endothelial dysfunction and cardiovascular disease: History and analysis of the clinical utility of the relationship. Biomedicines 2021; 9(6): 699.
[http://dx.doi.org/10.3390/biomedicines9060699] [PMID: 34203043]
[http://dx.doi.org/10.3390/biomedicines9060699] [PMID: 34203043]
[12]
Nastos C, Kalimeris K, Papoutsidakis N, et al. Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev 2014; 2014: 906965.
[http://dx.doi.org/10.1155/2014/906965] [PMID: 24799983]
[http://dx.doi.org/10.1155/2014/906965] [PMID: 24799983]
[13]
Xu S, Ilyas I, Little PJ, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: From mechanism to pharmacotherapies. Pharmacol Rev 2021; 73(3): 924-67.
[http://dx.doi.org/10.1124/pharmrev.120.000096] [PMID: 34088867]
[http://dx.doi.org/10.1124/pharmrev.120.000096] [PMID: 34088867]
[14]
Daiber A, Andreadou I, Oelze M, Davidson SM, Hausenloy DJ. Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure. Free Radic Biol Med 2021; 163: 325-43.
[http://dx.doi.org/10.1016/j.freeradbiomed.2020.12.026] [PMID: 33359685]
[http://dx.doi.org/10.1016/j.freeradbiomed.2020.12.026] [PMID: 33359685]
[15]
Katusic ZS. Vascular endothelial dysfunction: Does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 2001; 281(3): H981-6.
[http://dx.doi.org/10.1152/ajpheart.2001.281.3.H981] [PMID: 11514262]
[http://dx.doi.org/10.1152/ajpheart.2001.281.3.H981] [PMID: 11514262]
[16]
Goligorsky MS, Noiri E. Duality of nitric oxide in acute renal injury. Semin Nephrol 1999; 19(3): 263-71.
[PMID: 10226332]
[PMID: 10226332]
[17]
Ricard N, Bailly S, Guignabert C, Simons M. The quiescent endothelium: Signalling pathways regulating organ-specific endothelial normalcy. Nat Rev Cardiol 2021; 18(8): 565-80.
[http://dx.doi.org/10.1038/s41569-021-00517-4] [PMID: 33627876]
[http://dx.doi.org/10.1038/s41569-021-00517-4] [PMID: 33627876]
[18]
Augustin HG, Koh GY. Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology. Science 2017; 357(6353): eaal2379.
[http://dx.doi.org/10.1126/science.aal2379] [PMID: 28775214]
[http://dx.doi.org/10.1126/science.aal2379] [PMID: 28775214]
[19]
Florey. The endothelial cell. BMJ 1966; 2(5512): 487-90.
[http://dx.doi.org/10.1136/bmj.2.5512.487] [PMID: 5913081]
[http://dx.doi.org/10.1136/bmj.2.5512.487] [PMID: 5913081]
[20]
Tan Y, Mui D, Toan S, Zhu P, Li R, Zhou H. SERCA Overexpression improves mitochondrial quality control and attenuates cardiac microvascular ischemia-reperfusion injury. Mol Ther Nucleic Acids 2020; 22: 696-707.
[http://dx.doi.org/10.1016/j.omtn.2020.09.013] [PMID: 33230467]
[http://dx.doi.org/10.1016/j.omtn.2020.09.013] [PMID: 33230467]
[21]
Zhou LY, Zhai M, Huang Y, et al. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/FAM65B pathway. Cell Death Differ 2019; 26(7): 1299-315.
[http://dx.doi.org/10.1038/s41418-018-0206-4] [PMID: 30349076]
[http://dx.doi.org/10.1038/s41418-018-0206-4] [PMID: 30349076]
[22]
Liu Y, Lu T, Zhang C, et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol 2019; 71(4): 719-30.
[http://dx.doi.org/10.1016/j.jhep.2019.05.029] [PMID: 31201834]
[http://dx.doi.org/10.1016/j.jhep.2019.05.029] [PMID: 31201834]
[23]
Matsui N, Kasajima K, Hada M, et al. Inhibiton of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci 2005; 30(2): 103-10.
[http://dx.doi.org/10.2131/jts.30.103] [PMID: 15928458]
[http://dx.doi.org/10.2131/jts.30.103] [PMID: 15928458]
[24]
Zou G, Zhou Z, Xi X, Huang R, Hu H. Pioglitazone ameliorates renal ischemia-reperfusion injury via inhibition of NF-κB activation and inflammation in rats. Front Physiol 2021; 12: 707344.
[http://dx.doi.org/10.3389/fphys.2021.707344] [PMID: 34349671]
[http://dx.doi.org/10.3389/fphys.2021.707344] [PMID: 34349671]
[25]
Tamaki I, Hata K, Okamura Y, et al. Hydrogen flush after cold storage as a new end-ischemic ex vivo treatment for liver grafts against ischemia/reperfusion injury. Liver Transpl 2018; 24(11): 1589-602.
[http://dx.doi.org/10.1002/lt.25326] [PMID: 30120877]
[http://dx.doi.org/10.1002/lt.25326] [PMID: 30120877]
[26]
Baskin-Bey ES, Washburn K, Feng S, et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 2007; 7(1): 218-25.
[http://dx.doi.org/10.1111/j.1600-6143.2006.01595.x] [PMID: 17227570]
[http://dx.doi.org/10.1111/j.1600-6143.2006.01595.x] [PMID: 17227570]
[27]
Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284(1): G15-26.
[http://dx.doi.org/10.1152/ajpgi.00342.2002] [PMID: 12488232]
[http://dx.doi.org/10.1152/ajpgi.00342.2002] [PMID: 12488232]
[28]
Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79(20): 1881-94.
[http://dx.doi.org/10.1016/j.lfs.2006.06.024] [PMID: 16828807]
[http://dx.doi.org/10.1016/j.lfs.2006.06.024] [PMID: 16828807]
[29]
Chen W, Li D. Reactive oxygen species (ROS)-Responsive nanomedicine for solving ischemia-reperfusion injury. Front Chem 2020; 8: 732.
[http://dx.doi.org/10.3389/fchem.2020.00732] [PMID: 32974285]
[http://dx.doi.org/10.3389/fchem.2020.00732] [PMID: 32974285]
[30]
Mumic FT, Silveira MR, Vilalva KH, et al. Effect of irradiation with different laser wavelengths on oxidative stress of non-hepatectomized rats. Acta Cir Bras 2016; 31(Suppl. 1): 40-4.
[http://dx.doi.org/10.1590/S0102-86502016001300009] [PMID: 27142904]
[http://dx.doi.org/10.1590/S0102-86502016001300009] [PMID: 27142904]
[31]
Losada DM, Jordani ME, Jordani MC, et al. Should preconditioning hyperbaric oxygenation protect the liver against ischemia-reperfusion injury? An experimental study in a rat model. Transplant Proc 2014; 46(1): 56-62.
[http://dx.doi.org/10.1016/j.transproceed.2013.10.044] [PMID: 24507026]
[http://dx.doi.org/10.1016/j.transproceed.2013.10.044] [PMID: 24507026]
[32]
Hentia C, Rizzato A, Camporesi E, et al. An overview of protective strategies against ischemia/reperfusion injury: The role of hyperbaric oxygen preconditioning. Brain Behav 2018; 8(5): e00959.
[http://dx.doi.org/10.1002/brb3.959] [PMID: 29761012]
[http://dx.doi.org/10.1002/brb3.959] [PMID: 29761012]